Fibroblast growth factor 2 - A predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 442-447

  Rades, Dirk ^a   Setter, Cornelia ^a   Dahl, Olav ^b,c   Schild, Steven E ^d   Noack, Frank ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d MAYO CLINIC   (United States)

Author keywords

FGF 2 expression; fibroblast growth factor 2; Non small cell lung cancer; prognostic factors; radiotherapy; treatment outcomes

Indexed keywords

FGF-2 EXPRESSION; FIBROBLAST GROWTH FACTOR 2; NON SMALL CELL LUNG CANCER; PROGNOSTIC FACTORS; TREATMENT OUTCOMES;

BIOLOGICAL ORGANS; CELL CULTURE; CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; DISEASES; FAULT TOLERANT COMPUTER SYSTEMS; FIBROBLASTS; HEMOGLOBIN; NATURAL LANGUAGE PROCESSING SYSTEMS; PEPTIDES; RADIOTHERAPY; SURGERY; TOMOGRAPHY; TUMORS;

MULTIVARIANT ANALYSIS;

ANTINEOPLASTIC AGENT; FIBROBLAST GROWTH FACTOR 2; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ENDOSCOPY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SMOKING; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME;

ADENOCARCINOMA; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEMOGLOBIN A; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SEX FACTORS; SMOKING; TREATMENT OUTCOME;

EID: 83955161820     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.08.048     Document Type: Article

References (29)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66
2. M. Presta, P. Dell'Era, and S. Mitola Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis Cytokine Growth Factor Rev 16 2005 159 178
3. L.A. Byers, and J.V. Heymach Dual targeting of the vascular endothelial growth factor and epidermal growth factor receptor pathways: Rationale and clinical applications for non-small-cell lung cancer Clin Lung Cancer 8 Suppl. 2 2007 S79 S85
4. W. Berger, U. Setinek, and T. Mohr Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small lung cancer cells Int J Cancer 83 1999 415 423
5. A. Iwasaki, M. Kuwahara, and Y. Yoshinaga Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels as prognostic indicators in NSCLC Eur J Cardiothorac Surg 25 2004 443 448
6. Y. Shou, T. Hirano, and Y. Gong Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small cell lung cancer Br J Cancer 85 2001 1706 1712
7. I. Takanami, F. Tanaka, and T. Hashizume The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: An investigation of their expression as prognostic markers Eur J Cancer 32A 1996 1504 1509
8. T. Donnem, K. Al-Shibli, and S. Al-Saad Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: Coexpression with VEGFR-3 and PDGF-B predicts poor survival J Thorac Oncol 4 2009 578 585
9. R.M. Bremnes, C. Camps, and R. Sirera Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood Lung Cancer 51 2006 143 158
10. H. Kojima, N. Shijubo, and S. Abe Thymidine phosphorylase and vascular endothelial growth factor in patients with stage I lung adenocarcinoma Cancer 94 2002 1083 1093
11. M. Volm, R. Koomagi, and J. Mattern Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas Eur J Cancer 33 1997 691 693
12. D. Rades, C. Setter, and S.E. Schild Effect of smoking during radiotherapy, respiratory insufficiency, and hemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 71 2008 1134 1142
13. G.W. Barendsen Dose fractionation, dose rate and iso-effect relationships for normal tissue responses Int J Radiat Oncol Biol Phys 8 1982 1981 1997
14. M.C. Joiner, and A.J. van der Kogel The linear-quadratic approach to fractionation and calculation of isoeffect relationships G.G. Steel, Basic Clinical Radiobiology 2nd ed 1997 Oxford University Press New York 106 112
15. P. Vaupel, O. Thews, and A. Mayer Oxygenation status of gynecologic tumors: What is the optimal hemoglobin level? Strahlenther Onkol 178 2002 727 731
16. E.L. Kaplan, and P. Meier Non parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
17. C. Barclay, A.W. Li, and L. Geldenhuys Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene Clin Cancer Res 11 2005 7683 7691
18. B. Caglayan, A. Fidan, and B. Salepci Effects of prognostic factors and treatment on survival in advanced non-small cell lung cancer Tuberk Toraks 52 2004 323 332
19. H.C. Hsu, C.J. Wang, and E.Y. Huang Post-operative adjuvant thoracic radiotherapy for patients with completely resected non-small cell lung cancer with nodal involvement: Outcome and prognostic factors Br J Radiol 77 2004 43 48
20. J. Jaen Olasolo, E. Alonso Redondo, and A. Leon Jiminez Non-small lung cancer: Survival after radiotherapy and prognostic factors Arch Bronconeumol 39 2003 81 86
21. B. Jeremic, B. Milicic, and A. Dagovic Pretreatment prognostic factors in patients with early stage (I/II) non-small-cell lung cancer treated with hyperfractionated radiation therapy alone Int J Radiat Oncol Biol Phys 65 2006 1112 1119
22. B. Jeremic, B. Milicic, and L. Acimonic Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: Long-term results of a phase II study J Clin Oncol 23 2005 6873 6880
23. B. Jeremic, F. Casas, and L. Wang Radiation therapy for early stage (I/II) non-small cell lung cancer Front Radiat Ther Oncol 42 2010 87 93
24. M. Hoyer Improved accuracy and outcome in radiotherapy of lung cancer Radiother Oncol 87 2008 1 2
25. K. Munstedt, M. Volzing, and R. Von Georgi Hemoglobin levels during radiotherapy and their influence on local control and survival of patients with endometrial carcinoma Oncol Rep 11 2004 711 717
26. D. Rades, S. Lang, and S.E. Schild Prognostic value of the hemoglobin levels during concurrent radio-chemotherapy in the treatment of esophageal cancer Clin Oncol 18 2006 139 144
27. A. Becker, P. Stadler, and R.S. Lavay Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 46 2000 459 466
28. 2 histography in patients with advanced head and neck cancer Strahlenther Onkol 177 2001 462 468
29. 2 histography in patients with advanced head and neck cancer Radiother Oncol 57 2000 31 37